ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Lourdes Ibanez; Francis de Zegher; Rita Malpique; Firdevs Bas; Feyza Darendeliler; Flaminia Fanelli; Alessandra Gambineri; Judit Bassols; Abel Lopez-Bermejo; Barbara Obermayer-Pietsch; Veronika Tandl; Dorte Glintborg; Pernille Ravn; Barbara Dieris; Viola Singer; Thomas Reinehr; Ronnaug Odegard; Eszter Vanky

Journal title: Crossref

Journal number: 7

Journal publisher: Jorunal of the Endocrine Society

Published year: 2022

DOI identifier: 10.1210/jendso/bvac150.1382

ISSN: 2472-1972